Institution · Daniel den Hoed Kliniek
Most cited papers from Daniel den Hoed Kliniek
What are the most cited papers from Daniel den Hoed Kliniek?
The most cited paper from Daniel den Hoed Kliniek is "Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma" (Roger Stupp, Warren P. Mason, Martin J. van den Bent et al., 2005), with 22,109 citations. Next come "Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer" (5,583) and "Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia" (3,593).
Showing 50 of 60 papers. Every paper with more than 471 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren P. Mason, Martin J. van den Bent et al. · New England Journal of Medicine | 9 Mar 2005 | 22,109 |
| 2 | Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer Pieter van Hagen et al. · New England Journal of Medicine | 31 May 2012 | 5,583 |
| 3 | Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien et al. · New England Journal of Medicine | 12 Mar 2003 | 3,593 |
| 4 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang et al. · The Lancet | Feb 2005 | 2,723 |
| 5 | Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma Thierry O. Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine | 7 Dec 1995 | 2,458 |
| 6 | Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Carien L. Creutzberg, Wim LJ van Putten, Peter C.M. Koper et al. · The Lancet | Apr 2000 | 1,786 |
| 7 | Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition Mieke Kriege, Cecile T.M. Brekelmans, Carla Boetes et al. · New England Journal of Medicine | 28 Jul 2004 | 1,690 |
| 8 | Cremophor EL Hans A. J. Gelderblom, Jaap Verweij, Kees Nooter et al. · European Journal of Cancer | Sep 2001 | 1,658 |
| 9 | Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial Joop A. van Dongen · JNCI Journal of the National Cancer Institute | 19 Jul 2000 | 1,280 |
| 10 | Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Allan T. van Oosterom, Ian Robert Judson, Jaap Verweij et al. · The Lancet | Oct 2001 | 1,272 |
| 11 | A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors Pieter Mathijs Voorhoeve, Carlos le Sage, Mariëtte Schrier et al. · Cell | Mar 2006 | 1,270 |
| 12 | Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 Martin J. van den Bent, Alba Ariela Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology | 16 Oct 2012 | 1,236 |
| 13 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yongyu Wang, J.G.M. Klijn, Y ZHANG et al. · The Lancet | 25 Feb 2005 | 1,233 |
| 14 | Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Remi A. Nout, VTHBM Smit, Hein Putter et al. · The Lancet | Mar 2010 | 1,154 |
| 15 | A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome Frans G. A. van der Meché, Paul I.M. Schmitz, the Dutch Guillain–Barré Study Group* · New England Journal of Medicine | 23 Apr 1992 | 1,151 |
| 16 | Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Dieta Brandsma, Lukas J.A. Stalpers, Walter Taal et al. · The Lancet Oncology | 29 Apr 2008 | 1,131 |
| 17 | Response assessment criteria for brain metastases: proposal from the RANO group Nancy U. Lin et al. · The Lancet Oncology | 27 May 2015 | 1,117 |
| 18 | Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery Charles J. Vecht, Hanny Haaxma‐Reiche, Evert M. Noordijk et al. · Annals of Neurology | Jun 1993 | 1,055 |
| 19 | Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial Martin J. van den Bent, D Afra, Olivier De Witte et al. · The Lancet | 20 Aug 2005 | 1,035 |
| 20 | Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series Christine Desmedt, Fanny Piette, Sherene Loi et al. · Clinical Cancer Research | Jun 2007 | 990 |
| 21 | Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma Francesco Pignatti, Martin J. van den Bent, Desmond Curran et al. · Journal of Clinical Oncology | 15 Apr 2002 | 961 |
| 22 | Testicular germ-cell tumours in a broader perspective J. Wolter Oosterhuis, Leendert H. J. Looijenga · Nature reviews. Cancer | Mar 2005 | 932 |
| 23 | In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications Georges A. Wagnières, Willem M. Star, Brian C. Wilson · Photochemistry and Photobiology | Nov 1998 | 925 |
| 24 | Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade Sherene Loi, Benjamin Haibe‐Kains, Christine Desmedt et al. · Journal of Clinical Oncology | 30 Mar 2007 | 850 |
| 25 | The spectrum of antecedent infections in Guillain-Barre syndrome Bart C. Jacobs, P H Rothbarth, Frans G. A. van der Meché et al. · Neurology | Oct 1998 | 829 |
| 26 | Intragenic ERBB2 kinase mutations in tumours Philip Stephens et al. · Nature | Sep 2004 | 793 |
| 27 | Late cardiotoxicity after treatment for Hodgkin lymphoma Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin et al. · Blood | 21 Nov 2006 | 766 |
| 28 | Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed | Aug 2001 | 752 |
| 29 | Coronary angiography with multi-slice computed tomography Koen Nieman, Matthijs Oudkerk, Benno J.W.M. Rensing et al. · The Lancet | Feb 2001 | 726 |
| 30 | Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman et al. · Journal of Clinical Oncology | 29 Jul 2003 | 725 |
| 31 | The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer Maria E.L. van der Burg, Mat van Lent, Marc E Buyse et al. · New England Journal of Medicine | 9 Mar 1995 | 724 |
| 32 | Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials INTERNATIONALCOLLABORATIVEHYPERT, Charles A. Vernon, Jeffrey W. Hand et al. · International Journal of Radiation Oncology*Biology*Physics | Jul 1996 | 723 |
| 33 | Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Frank J. Lagerwaard, P.C. Levendag, PeterJ.C.M Nowak et al. · International Journal of Radiation Oncology*Biology*Physics | Mar 1999 | 722 |
| 34 | Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity C. B. H. W. Lamers, Stefan Sleijfer, Sabine van Steenbergen et al. · Molecular Therapy | 19 Feb 2013 | 720 |
| 35 | TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility Remco van Horssen, Timo L.M. ten Hagen, Alexander M.M. Eggermont · The Oncologist | Apr 2006 | 713 |
| 36 | Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations Sunil R. Lakhani et al. · JNCI Journal of the National Cancer Institute | 5 Aug 1998 | 708 |
| 37 | CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines Vincent Grégoire, Peter C. Levendag, Kian K Ang et al. · Radiotherapy and Oncology | Dec 2003 | 680 |
| 38 | Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas Martin J. van den Bent, JS Wefel, David Schiff et al. · The Lancet Oncology | 7 Apr 2011 | 655 |
| 39 | MicroRNA Related Polymorphisms and Breast Cancer Risk Sofia Khan et al. · PLoS ONE | 12 Nov 2014 | 638 |
| 40 | The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age Evert M. Noordijk, Charles J. Vecht, Hanny Haaxma-Reiche et al. · International Journal of Radiation Oncology*Biology*Physics | Jul 1994 | 637 |
| 41 | CCAT2 , a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer Hui Yvonne Ling et al. · Genome Research | 24 Jun 2013 | 614 |
| 42 | Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype Sunil R. Lakhani et al. · Clinical Cancer Research | 15 Jul 2005 | 613 |
| 43 | The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients* J.G.M. Klijn, P.M.J.J. Berns, Paul I.M. Schmitz et al. · Endocrine Reviews | Feb 1992 | 598 |
| 44 | Pharmacological Effects of Formulation Vehicles Albert J. ten Tije, Jaap Verweij, Walter J. Loos et al. · Clinical Pharmacokinetics | 2003 | 595 |
| 45 | Optical properties of intralipid: A phantom medium for light propagation studies Stephen T. Flock, Steven L. Jacques, Brian C. Wilson et al. · Lasers in Surgery and Medicine | 1992 | 580 |
| 46 | Risk of endometrial cancer after tamoxifen treatment of breast cancer Flora E. van Leeuwen, Alexandra W. van den Belt‐Dusebout, F.E. Van Leeuwen et al. · The Lancet | Feb 1994 | 571 |
| 47 | Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial Thomas Suter, Marion Jennifer Procter, Dirk J. van Veldhuisen et al. · Journal of Clinical Oncology | 24 Jul 2007 | 568 |
| 48 | Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy Vincent Koppelmans, Monique M.B. Breteler, Willem J. Boogerd et al. · Journal of Clinical Oncology | 28 Feb 2012 | 562 |
| 49 | Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial Saskia Litière, Gustavo Werutsky, Ian S. Fentiman et al. · The Lancet Oncology | 26 Feb 2012 | 558 |
| 50 | Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability Joep C. Stroom, Hans C.J. de Boer, Henk Huizenga et al. · International Journal of Radiation Oncology*Biology*Physics | Mar 1999 | 551 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.